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Abstract	  The	   over-­‐expression	   of	   proteins	   in	   recombinant	   host	   cells	   often	   requires	   a	   significant	  amount	  of	  resources	  causing	  an	  increase	  in	  the	  metabolic	  load	  for	  the	  host.	  This	  results	  in	  a	  variety	  of	  physiological	  responses	   leading	  to	  altered	  growth	  parameters,	   including	  growth	  inhibition.	   Moreover,	   the	   expression	   of	   other	   plasmid-­‐encoded	   genes	   such	   as	   antibiotic	  resistance	  genes	  or	  repressor	  proteins	  may	  also	  alter	  growth.	  	  In	   this	   work,	   we	   have	   developed	   a	   second	   generation	   of	   an	   Escherichia	   coli	   expression	  system	  with	   an	   antibiotic-­‐free	   plasmid	  maintenance	  mechanism	  based	   on	   an	   auxotrophic	  marker	  (glyA).	  Metabolic	  burden	  related	  to	  plasmid	  maintenance	  and	  heterologous	  protein	  expression	  has	  been	  minimized	  by	  tuning	  the	  expression	  levels	  of	  a	  repressor	  protein	  (LacI)	  and	   glyA	   using	   a	   selected	   library	   of	   promoters	   and	   applying	   synthetic	   biology	   tools	   that	  allow	  the	  rapid	  construction	  of	  vectors.	  	  We	  apply	  our	  engineered	  antibiotic-­‐free	  expression	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system	  to	  the	  FucA	  over-­‐production,	  showing	  increased	  production	  levels.	  Our	   results	   showed	   that	   the	   aforementioned	   approaches	   are	   of	   paramount	   importance	   in	  order	  to	  increment	  the	  protein	  production	  in	  terms	  of	  mass	  and	  activity.	  Acknowledgements:	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1 Introduction	  	  Among	   the	  many	  systems	  available,	   the	  gram	  negative	  bacterium	  Escherichia	  coli	   remains	  one	  of	  the	  most	  versatile	  and	  used	  host	  for	  the	  production	  of	  heterologous	  proteins,	  because	  of	   its	   rapid	   growth	   rate,	   the	   easiness	   to	   attain	   high	   cell	   density	   cultures	   on	   inexpensive	  substrates,	  its	  well-­‐characterized	  genetics	  and	  the	  availability	  of	  excellent	  genetic	  tools	  (1).	  Efforts	  in	  developing	  strategies	  to	  maximize	  the	  productivity	  in	  E.	  coli	  are	  well	  documented	  in	  literature	  (2)(3).	  	  Extensive	  research	  has	  been	  performed	  over	  the	  past	  years	  in	  order	  to	  improve	  recombinant	  protein	  production	   in	   this	  cell	   factory,	   including	   the	  optimization	  of	  process	  parameters	  such	  as	  the	  growth	  temperature,	  the	  media	  composition,	  the	  induction	  conditions,	  as	  well	  as	  engineering	  the	  expression	  system	  (4).	  	  In	  particular,	  thanks	  to	  the	  development	  of	  the	  synthetic	  biology,	  new	  methods	  and	  tools	  to	  speed	   up	   and	   standardize	   strain	   engineering	   have	   been	   established.	   Compared	   with	  conventional	  DNA	  cloning	  protocols,	   these	  advanced	  DNA	  assembly	  tools	  offer	  an	  efficient	  approach	   to	   construct	   multi-­‐gene	   pathways	   in	   a	   one-­‐step,	   scar-­‐less,	   and	   sequence-­‐independent	  manner.	  	  Specifically,	  collections	  of	  standard	  biological	  parts	  (BioBricks)	  allow	  for	  the	  fast	  assembly	  of	  new	  functions	   in	  many	  organisms	  (5).	  For	  example,	   individual	  parts	  or	  combinations	  of	  parts	  that	  encode	  defined	  functions	  can	  be	  independently	  tested	  and	  characterized	  in	  order	  to	  improve	  the	  expression	  system.	  Besides,	  parts	  or	  devices	  that	  do	  not	  function	  as	  expected	  can	  be	  readily	  modified	  or	  removed(6).	  DNA	  construction	  based	  on	  the	  BioBrick	  theory	  has	  become	  a	  key	  part	  of	  most	  metabolic	  engineering	  projects	  and	  genetic	  circuits	  design.	  The	  BioBrick	  concept	  exploits	   the	  advantage	   that	   the	  same	  promoters,	   ribosome	  binding	  sites,	  expression	  tags,	  antibiotic	  resistances	  and	  origins	  of	  replication	  are	  frequently	  reused,	  with	  only	  the	  genes	  of	  interest	  being	  varied	  (7)(8).	  Thus,	  with	  a	  series	  of	  standardized	  biological	  parts,	  researchers	  should	  be	  able	  to	  quickly	  assemble	  biological	  parts	  (bricks)	  into	  different	  biological	  functions,	  pathways	  and	  mechanisms.	  	  The	   recent	   advances	   on	   synthetic	   biology	  have	   allowed	   to	  produce	  novel	   compounds	   (9),	  including	  high-­‐performance	  enzymes	  with	  applications	   in	   the	  biotechnological	  sector	  such	  as	   the	  non	   ribosomal	   peptides	   synthetases	   (NRPs)	   and	   the	  polyketide	   synthetases	   (PKSs)	  (10)(11).	  In	  this	  context,	  aldolases	  constitute	  one	  of	  the	  most	  interesting	  groups	  of	  enzymes	  employed	   for	   organic	   synthesis	   of	   carbohydrates,	   aminoacids	   and	   hydroxyacids	   (12).	  Aldolases	   belong	   to	   the	   class	   of	   lyases,	   which	   catalyze	   C-­‐C	   bond	   formation	   leading	   to	  enantiomerically	  pure	  products,	  even	  when	  the	  starting	  materials	  are	  non-­‐chiral	  substrates.	  In	  particular,	  L-­‐Fuculose	  phosphate-­‐aldolase	  (FucA)	  catalyzes	   the	  reversible	  reaction	  of	  L-­‐fuculose-­‐1-­‐phosphate	  to	  dihydroxyacetone	  phosphate	  (DHAP)	  and	  L-­‐lactaldehyde	  in	  vivo.	  E.	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coli	  has	  been	  proven	  to	  be	  an	  efficient	  platform	  for	  soluble	  overexpression	  of	  a	  wide	  range	  of	   aldolases,	   both	   endogenous	   and	   from	   other	   bacteria	   (13)(14).	   Initial	   FucA	   over	  expression	  studies	  in	  our	  laboratory	  were	  carried	  out	  when	  the	  gene	  fucA	   from	  E.	  coli	  K12	  was	   cloned	   into	   a	   plasmid	   vector	   controlled	   by	   a	   Trc	   promoter	   (pTrcfucA)	   and	  overexpressed	   as	   a	   recombinant	   his-­‐tag	   fusion	   protein	   (13).	   After	   that,	   Vidal	   et	   al.	   (15),	  switched	   to	   a	   commercially	   available	   expression	   system	   (Qiagen),	   consisting	   of	   the	   M15	  strain	   and	   a	   two-­‐plasmid	   system	   including	   the	   pQE40	   expression	   vector,	   which	   uses	   the	  stronger	  T5	  promoter.	  	  This	  system	  was	  used	  to	  overproduce	  a	  range	  of	  different	  aldolases,	  including	   a	  DHAP-­‐dependent	   aldolase,	   the	   rhamnulose	  1-­‐phosphate	   aldolase	   (RhuA)	   (16).	  Moreover,	   this	   expression	   system	  was	   further	   evolved	   into	   an	   auxotrophic	  marker-­‐based	  plasmid	   maintenance	   system	   by	   knocking	   out	   the	   glyA	   gene	   from	   the	   M15	   prototrophic	  strain	   and	   by	   constructing	   a	   pQE-­‐40	   derived	   plasmid	   containing	   the	   auxotrophic	  marker	  gene	   (glyA)	  under	   the	   control	   of	   a	  weak	   constitutive	  promoter	   (17).	  The	  E.	  coli	  glyA	   gene	  encodes	  for	  the	  enzyme	  serine	  hydroxymethyl	  transferase	  (SHMT).	  This	  46	  kDa	  enzyme	  has	  two	  activities:	  i)	  threonine	  aldolase	  activity,	  which	  catalyzes	  the	  reversible	  interconversion	  between	   L-­‐threonine	   and	   glycine	   plus	   acetaldehyde,	   and	   ii)	   serine	   hydroxymethyl	  transferase	   activity,	   which	   catalyzes	   the	   reversible	   interconversion	   between	   serine	   and	  glycine	  (18).	  Previous	   studies	   have	   shown	   that	   the	   glyA-­‐based	   antibiotic-­‐free	   system	   of	   plasmid	  maintenance	  in	  E.	  coli	  is	  a	  promising	  alternative	  approach	  to	  the	  use	  of	  antibiotic	  selection	  markers.	  However	  increased	  SMHT	  levels	  might	  burden	  the	  cell’s	  metabolisms,	  which	  lead	  to	  a	  decrease	  in	  activity	  and	  specific	  productivity	  profiles	  compared	  to	  the	  original	  system.	  Furthermore,	   according	   to	   Glick	   (19),	   the	   biosynthesis	   of	   proteins	   is	   an	   energy	   intensive	  process	   and	   it	   is	   therefore	  not	   surprising	   that	   the	  overproduction	  of	   one	  or	  more	   foreign	  proteins	  encoded	  within	  the	  DNA	  may	  cause	  segregational	  instability,	  where	  it	  is	  often	  all	  or	  part	  of	  the	  foreign	  gene	  of	  interest	  that	  is	  deleted	  from	  the	  plasmid.	  Moreover,	   the	   presence	   of	   a	   second	   antibiotic	   resistance	   marker	   in	   the	   second	   plasmid	  (pREP4),	  expressing	   the	   lacI	   repressor,	   impedes	   the	  achievement	  of	  an	  expression	  system	  completely	   free	   from	  the	  use	  of	  antibiotics.	  For	   these	  reasons,	   further	  studies	   to	   fine-­‐tune	  the	  glyA	  and	  lacI	  expression	  levels	  and	  to	  eliminate	  the	  pREP4	  plasmid	  are	  needed	  in	  order	  to	  overcome	  these	  limitations.	  	  In	   this	   study,	   the	   fucA	   gene	  has	  been	  cloned	   into	   the	  Vidal	   system	   in	  order	   to	  obtain	  high	  intracellular	  expression	   levels.	  Furthermore,	   through	  the	  application	  of	  different	  synthetic	  biology	   approaches,	   the	   design	   and	   construction	   of	   an	   M15/pQE40-­‐derived	   expression	  system	  consisting	  of	  a	  single	  vector	  have	  been	  possible.	  Moreover,	  the	  expression	  levels	  of	  the	  key	  genes	  lacI	  and	  glyA	  have	  been	  tuned	  by	  the	  use	  of	  different	  constitutive	  promoters.	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2 Materials	  and	  methods	  
	  
2.1 Bacterial	  strain	  
In	   this	   work,	   the	   K12	   derived	   strains	   E.	   coli	   M15	   and	   M15ΔglyA	   have	   been	   used	   and	   were	  
constructed	  as	  previously	  described	  (17).	  The	  strain	  E.	  coli	  DH5α	  has	  been	  used	  for	  expression	  
vector	  engineering	  purposes,	  whereas	  the	  M15ΔglyA	  strain	  has	  been	  used	  for	  recombinant	  FucA	  
expression.	   Bacterial	   strains	   and	   plasmids	   used	   in	   this	   study	   are	   summarized	   in	   table	   1.	   The	  
strains	   were	   stored	   at	   -­‐80°C	   in	   cryo-­‐stock	   aliquots	   prepared	   from	   exponential	   phase	   cultures	  
grown	  in	  Luria-­‐Bertani	  (LB)	  medium.	  
	  Tabla	  1	  List	  of	  Escherichia	  coli	  strains	  and	  plasmids	  used	  
Strains	  and	  plasmids	   Characteristics	   Reference	  or	  source	  
E.	  coli	   	   	  
M15	   K12	  derived	   QIAGEN	  (Villarejo	  and	  Zabin	  1974;	  
Zamenhof	  and	  Villarejo,	  1972)	  
	   6	  
	  	  	  M15ΔglyA	   Deletion	  of	  the	  glyA	  locus	  of	  the	  chromosome	   (17)	  
DH5α	   Cloning	  application	   Invitrogen	  
Vectors	   	   	  
pTrcfuc	   pTrc	  HisC	  vector	  with	  the	  fucA	  gene	  cloned	  	   Garcia-­‐junceda	  et	  al.,	  1995	  (13)	  
pQE-­‐FucA	   pQE-­‐40	   derived	   (QIAGEN)	   with	   fucA	   gene	  
cloned	  
This	  study	  
pREP4	   LacIq	  kanR	   Qiagen	  	  
pQEαβFucA	   pQE-­‐FucA	   derived	   with	   fragment,	   containing	  
the	   glyA	   gene,	   under	   P3	   promoter	  
transcriptional	  control	  
This	  study	  
pSB1C3_GG	   High-­‐copy	   camR,	   used	   for	   BioBricks	   standard	  
assembly	   vector,	   carried	   the	   mCherry	   gene,	  
with	   two	   BsaI	   restrictions	   sites	   with	   the	   two	  
different	  overhangs.	  
Synth-­‐bio	  group	   (group	   leader	  A.	   Jaramillo).	  
Institute	   of	   System	   and	   Synthetic	   Biology	  
(iSSB),	   university	   of	   Évry-­‐Val-­‐d’Essonne	  
Genopole®	  (France)	  
pSB1C3_GG	  J231XX-­‐lacI-­‐glyA	   pSB1C3_GG	  derived	  with	  a	   library	  of	  promoter	  
for	  lacI	  and	  glyA	  expression	  
This	  study	  
pQE-­‐FucA_puzzle	  	  (J23110)	   pQE-­‐FucA	  derived	  with	  insertion	  of	  the	  cassette	  




	  	  AmpR-­‐	  
pQE-­‐FucA_puzzle	  (J23110)	  derived	  without	  the	  
bla	  gene	  
This	  study	  	  
	  
	  
2.2 Molecular	  biology	  techniques	  
Plasmid	   and	   strain	   constructions.	   Plasmid	   DNA	   and	   DNA	   fragments	   were	   isolated	   or	   purified	  
using	   PreYieldTM	   plasmid	   miniprep	   system	   and	   Wizard®	   SV	   gel	   and	   PCR	   clean-­‐up	   system	  
(Promega)	   according	   to	   the	  manufacturer’s	   instructions.	   Restriction	   enzymes	  were	   purchased	  
from	  Thermo	  Scientific	  and	  T4	  DNA	  ligase	  from	  Roche.	  Transformation	  of	  E.	  coli	  DH5α,	  M15	  and	  
M15ΔglyA	   competent	   cells	  with	   the	  DNA	   ligation	   reactions	  was	  performed	  by	  electroporation	  
using	   a	   GenePulser	  MXcellTM	   electroporator	   from	   Bio-­‐Rad.	   Transformants	   were	   grown	   on	   LB-­‐
agar	  medium	  plates	  containing	   the	  corresponding	  amount	  of	  antibiotic	  or	  on	  defined	  medium	  
(DM)-­‐agar	   plates.	   All	   the	   selected	   clones	   were	   confirmed	   by	   colony-­‐PCR,	   single	   or	   double	  
restriction	  digests	  and	  DNA	  sequencing.	  
	  
PCR	  reactions.	  For	  fragments	  up	  to	  2.0	  Kb,	  PCR	  assays	  were	  carried	  out	  using	  KOD	  Polymerase	  
Novagen	  from	  Merck	  Biosciences.	  For	  longer	  DNA	  sequences,	  PCR	  assays	  were	  performed	  using	  
the	  Phusion	  high-­‐fidelity	  DNA	  polymerase	  (Thermo	  Scientific),	  following	  the	  guidelines	  provided	  
by	  the	  manufacturer.	  For	  the	  verification	  of	  ligation	  reactions	  and	  transformations,	  colony	  PCRs	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were	  performed	  using	  the	  GoTaq®	  master	  mix	  (Promega).	  All	  the	  primers	  used	  are	  listed	  in	  Table	  
2.	  
	   Tabla	   2	   List	  of	  primers	  used	  in	  this	  study.	  The	  Tm,	  melting	  temperature	  in	  °C,	  and	  the	  size	   in	  pb	  are	  described.	  
Bases	  in	  bold	  represent	  the	  BsaI	  enzyme	  recognition	  site;	  underline	  bases	  represent	  the	  four	  different	  overhangs	  
used	  for	  this	  study;	  red	  bases	  indicate	  the	  RBS	  BBa_B0034	  for	  the	  lacI	  gene	  and	  the	  green	  bases	  specify	  the	  RBS	  
J61100	  for	  the	  glyA	  gene.	  





FucA	  FW	   CGGTACGTGGATCCATGGAACGAAATAAACTTGCTCG	   61	   37	  
FucA	  REW	   GCTAGTCCAAGCTTCTCTTCAATTCGTAACCCATAGG	   60	   37	  
αβT	  FW	   GCTTGATCTCCGGAGTGAAGACGAAAGGGC	   61	   31	  
αβT	  REW	   CGTCCATGTCTAGAGGGCGGATTTGTCCTACTC	   63	   33	  
GG_lacI	  FW	   TTGGTCTCTTAGC2TCTAGAGAAAGAGGAGAAATACTAGGTGAAACCAGTAACGTTATACG	   59	   60	  
GG_lacI	  REW	   TTGGTCTCTTCCA3TTCAAGATCTTCACTGCCCGCTTTCC	   61	   39	  
GG_glyA	  FW	   TTGGTCTCTTGGA3GAAAGAGGGGACAAACTAGTATGTTAAAGCGTGAAATGAA	   58	   53	  
GG_glyA	  REW	   TTGGTCTCTCGCT4GATAACGTAGAAAGGCTTCC	   58	   33	  
PJ1_FW	   GCTAAGGATGATTTCTGGAATTC	   59	   23	  
PJ2_FW	   GCTAAGGCGGACTGCAGGAAGAC	   58	   23	  
PJ_REW	   TGGCCA	  CGATAACGTAGAAAGGCTTCC	   60	   27	  
J23100_FW	   TTGGTCTCTCGCT1TTGACGGCTAGCTCAGTCCTAGGTACAGTGCTAGC2TGAGACCTT	   	   	  
J23100_REW	   AAGGTCTCAGCTA2GCACTGTACCTAGGACTGAGCTAGCCGTCAAAGCG1AGAGACCAA	   	   	  
J23110_FW	   TTGGTCTCTCGCT1TTTACGGCTAGCTCAGTCCTAGGTACAATGCTAGC2TGAGACCTT	   	   	  
J23110_REW	   AAGGTCTCAGCTA2GCATTGTACCTAGGACTGAGCTAGCCGTAAAAGCG1AGAGACCAA	   	   	  
J23111_FW	   TTGGTCTCTCGCT1TTGACGGCTAGCTCAGTCCTAGGTATAGTGCTAGC2TGAGACCTT	   	   	  
J23111_REW	   AAGGTCTCAGCTA2GCACTATACCTAGGACTGAGCTAGCCGTCAAAGCG1AGAGACCAA	  	  	   	   	  
J23117_FW	   TTGGTCTCTCGCT1TTGACAGCTAGCTCAGTCCTAGGGATTGTGCTAGC2TGAGACCTT	   	   	  







The	  four	  promoters	  used	  (J23100,	  J23111,	  J23110	  and	  J23117)	  in	  this	  study	  were	  selected	  from	  a	  
small	  combinatorial	  library	  of	  constitutive	  promoters	  (Figure	  1)	  (Registry	  for	  Standard	  Biological	  
Parts,	   http//parts.igem.com).	   Each	   promoter	  was	   synthetized	   by	   oligonucleotide	   hybridization	  
including	  two	  BsaI	  sites	  with	  2	  different	  overhangs	  at	  both,	  5’	  and	  3’	  terminus.	  
	  	  BsaI	  enzyme	  recognition	  site 
RBS	  BBa_B0034	  (http://parts.igem.org/Part:BBa_B0034) RBS	  BBa_J61100	  (http://parts.igem.org/Part:BBa_J61100) 
Legend 
	  	  	  1,2,3,4	  	  Four	  different	  bp	  overhang	  for	  the	  BsaI	  enzyme	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PCR,	  agarose	  gel	  electrophoresis	  and	  DNA	  sequencing	  were	  performed	  to	  check	  all	  the	  cloning	  
reactions.	   PCR	   verification	   of	   plasmid	   constructs	   was	   carried	   out	   using	   GoTaq®	   with	   the	  
following	  PCR	  program:	  95°C	  for	  45	  s,	  55–58°C	  for	  45	  s,	  and	  72°C	  for	  0.5–3.5	  min,	  for	  a	  total	  of	  
30	  cycles	  and	  a	  final	  extension	  of	  72°C	  for	  5	  min.	  
	  
	  Fig.	   1	   A)	   The	   J23119	   promoter	   series	   is	   a	   family	   of	   constitutive	   promoter	   parts	   isolated	   from	   a	   small	   combinatorial	  library.	  J23119	  is	  the	  wild	  type	  /wt)	  promoter	  sequence	  and	  the	  strongest	  member	  of	  the	  family.	  B)	  Reported	  activities	  of	  the	   promoters	   are	   given	   as	   the	   red	   fluorescence	   protein	   (RFP)	   relative	   fluorescence	   (in	   arbitrary	   units,	   AU),	   pSB1A2	  plasmid	  (Registry	  for	  Standard	  Biological	  Parts,	  http//parts.igem.org/parts:	  pSB1A2)	  in	  strain	  TG1	  grown	  in	  LB	  media	  to	  saturation.	  The	  strength	  of	  the	  promoters	  goes	  from	  the	  weakest	  to	  the	  strongest,	  as	  the	  orientation	  of	  the	  green	  arrow	  on	  left	  hand	  side	  of	  the	  figure.	  The	  four	  promoters	  used	  in	  this	  study	  are	  marked	  with	  a	  green	  box	  (J23110,	  J23111,	  J23110,	  J23117).	  
2.3 Plasmid	  constructs	  
pQE-­‐FucA:	  The	  commercial	  vector	  pQE-­‐40	  (Qiagen)	  was	  used	  as	  reference	  expression	  vector	  for	  
the	  protein	  of	  interest,	  FucA.	  This	  expression	  vector	  is	  based	  on	  the	  IPTG-­‐induced	  T5	  promoter,	  
derived	  from	  the	  T5	  phage.	   	  This	  promoter	   is	  recognized	  by	  E.	  coli	  RNA	  polymerase,	  and	  has	  a	  
double	   lac	   operator	   (lac	  O)	   repression	  module	   in	   series	   to	  provide	   tightly	   regulated	  and	  high-­‐
level	   expression	   of	   recombinant	   proteins	   (Figure.	   2A).	   The	   fucA	   gene	  was	   amplified	   from	   the	  
pTrcfuc	   vector	   using	   the	   FucA	   FW	   and	   REW	   primers	   (Table	   2).	   Thereafter,	   the	   0.65	   Kbp	   PCR	  
fragment	  was	  digested	  with	  the	  restriction	  enzymes	  BamHI	  and	  HindIII	  and	  subsequently	  cloned	  
into	  the	  pQE-­‐40	  vector	  linearized	  with	  the	  same	  enzymes,	  yielding	  pQE-­‐FucA	  (Figure.	  2B).	  E.	  coli	  
M15	   [pREP4]	   cells	   were	   transformed	  with	   the	   ligation	   reaction,	   and	   the	   positive	   clones	  were	  
selected	  by	  growing	  on	  LB	  plates	  containing	  of	  ampicillin	  and	  kanamycin.	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  Fig.	  2	   A)	  T5	  promoter	  region	  from	  the	  pQE-­‐40	  expression	  vector.	  The	  lac	  O	  sequences	  and	  the	  -­‐
35	   and	   -­‐10	   regions	   are	   shown.	   B)	   pQE-­‐FucA	   expression	   vector	   obtained	   by	   cloning	   the	   PCR-­‐
amplified	  fucA	  gene	  into	  the	  pQE-­‐40	  vector.	  PT5,	  promoter	  T5;	  6xHis,	  histidine	  affinity	  tag	  coding	  
sequence;	  FucA,	   fucA	   gene;	  MCS,	  multi	   cloning	  site;	   Lt0,	   lambda	   t0	   transcriptional	   termination	  
region;	  rrnBT1,	  transcriptional	  termination	  region;	  ColE1,	  replication	  origin	  and	  AmpR,	  ampicillin	  
resistance	  gene.	  
	  
pQEαβFucA:	   The	   DNA	   fragment	   comprising	   the	   glyA	   gene	   with	   its	   own	   promoter	   and	   its	   3’	  
termination	  region	  (designated	  as	  αβTerminator)	  was	  amplified	  using	  the	  KOD	  polymerase	  and	  
pQEαβRham	   (17)	   as	   template	   DNA.	   The	   resulting	   1,784	   Kbp	   fragment	   was	   then	   digested	   by	  
BspEI	  and	  XbaI	  and	  subsequently	  ligated	  into	  the	  pQE-­‐FucA	  vector	  previously	  linearized	  with	  the	  
same	   enzymes,	   obtaining	   the	   pQEαβFucA.	   The	   ligation	   reaction	   was	   transformed	   into	   E.	   coli	  
M15ΔglyA[pREP4]	   competent	   cells	   and	   the	   transformants	   selected	   on	   LB	   plates	   containing	  
ampicillin	  and	  kanamycin.	  	  	  
	  Fig.	   3	   pQEαβFucA	  expression	  vector.	   	  PT5,	  promoter	  T5;	  6xHis,	  histidine	  affinity	  tag	  coding	  
sequence;	   FucA,	   fucA	   gene;	   ‘MCS,	   multi	   cloning	   site;	   Lt0,	   lambda	   t0	   transcriptional	  
termination	   region;	   glyA,	   glyA	   gene;	   T,	   termination	   sequence	   of	   the	   glyA	   gene;	   ColE1,	  
replication	  origin	  and	  AmpR,	  ampicillin	  resistance	  gene.	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BioBrick-­‐based	  vectors	  (pSB1C3-­‐J231XX_lacIglyA).	  	  
The	   BioBrick	   vectors	  were	   assembled	   using	   the	   golden	   gate	   technique	   (23).	   The	  Golden	  Gate	  
method	  exploit	   the	  ability	  of	   type	   IIs	   endonucleases	   to	   cleave	  DNA	  outside	  of	   the	   recognition	  
sequence	  leaving	  an	  overhang.	  In	  this	  study	  BsaI	  restriction	  enzyme	  and	  its	  four	  bp	  overhangs	  is	  
used.	  	  
The	   lacI	   and	  glyA	   genes	   for	   the	   golden	   gate	   reaction	  were	   amplified	   from	   the	  pREP4	   and	   the	  
pQEαβFucA	  vectors,	  respectively	  with	  the	  GG_lacI	  FW	  and	  REW	  primers	  and	  with	  the	  GG_glyA	  
FW	  and	  REW	  primers	  (Table	  2),	  obtaining	  the	   lacI_GG	  and	  glyA_GG	  modules.	  For	  convenience,	  
the	  starting	  BioBrick	  vector	  pSB1C3_GG,	  the	  promoters	  and	  the	  PCR	  products	  were	  diluted	  to	  a	  
final	  concentration	  of	  69	   fmol·∙μL-­‐1.	  To	  each	  reaction,	  0.5	  μL	  of	  BsaI	  and	  T4	   ligase	  were	  added.	  
Final	  reactions	  were	  incubated	  in	  a	  thermocycler	  as	  follows:	  25-­‐30	  cycles,	  cycling	  between	  37	  °C	  
3	  min	  and	  16	  °C	  4	  min,	  ending	  with	  5	  min	  at	  50	  °C	  and	  5	  min	  at	  80	  °C.	  Four	  BioBrick	  constructs	  
were	  assembled,	  each	  one	  with	  a	  different	  constitutive	  promoter	  to	  tune	  the	  expression	  levels	  
of	   lacI	   and	   glyA	   genes.	   The	   four	   vectors	   were	   named	   pSB1C3-­‐J231XX	   where	   the	   double	   X	  
represents	   the	   last	   two	   digits	   of	   the	   promoter	   name.	   Finally,	   2-­‐5	   μL	   of	   assembly	   BioBrick	  
constructs	  were	  transformed	  into	  50	  μL	  of	  E.	  coli	  DH5α	  competent	  cells	  and	  plated	  on	  LB	  plates	  
containing	   chloramphenicol.	   Plasmids	   were	   isolated	   from	   white	   colonies	   and	   validated	   as	  
described	  in	  section	  2.2.	  	  
	  
	  
pQE-­‐FucA	  puzzle	  (J23110).	  Constructing	  new	  vector	  starting	  from	  the	  pQE-­‐FucA	  and	  the	  BioBrick	  
vector	  requires	  just	  two-­‐assembly	  step	  (Figure	  4).	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  Fig.	   4	   Strategy	   for	   pQE-­‐FucA_puzzle	   (J23110)	   construction.	   A)	   PCR	   amplification	   lacI-­‐
glyA	  cassette	  using	  plasmid	  SB1C3-­‐J23110	  as	  template	  and	  the	  primers	  PJ/2_FW	  and	  PJ-­‐REW.	  B)	  Double	  digestion	  of	  pQE-­‐FucA	  with	  Bpu10I	  and	  MscI.	  C)	  Final	  ligation	  step	  of	  the	  PCR-­‐amplified	   fragment	   (in	   step	   A)	   into	   the	   pQE-­‐FucA_puzzle	   (J23110)	   expression	  vector.	  
	  
	  
The	  expression	  cassette	  J23110-­‐lacI-­‐glyA	  was	  amplified	  from	  the	  plasmid	  SB1C3-­‐J23110	  by	  PCR	  
using	  the	  Phusion	  high	  fidelity	  polymerase	  (NEB)	  and	  the	  PJ/2_FW	  and	  PJ_REW	  as	  amplification	  
primers	   (Table	   2).	   Both	   the	   PCR	   product	   and	   the	   destination	   vector	   pQE-­‐FucA	  were	   digested	  
with	   restriction	   enzymes	   Bpu10I	   and	   MscI	   and	   subsequently	   purified	   after	   agarose	   gel	  
electrophoresis.	   The	   expression	   cassette	   was	   cloned	   into	   the	   pQE-­‐FucA	   (double	   digested)	  
obtaining	  the	  pQE-­‐FucA_puzzle	  (J23110).	  Finally,	  the	  ligation	  product	  was	  transformed	  into	  the	  
M15ΔglyA	   competent	   cells	   obtaining	   the	  M15ΔglyA	   pQE-­‐FucA_puzzle	   (J23110).	   Transformants	  
were	  isolated	  and	  correct	  plasmid	  sizes	  were	  verified.	  
	  
pQE-­‐FucA_puzzle	   (J23110)_AmpR−.	   The	   vector	   pQE-­‐FucA_puzzle	   (J23110)	  was	   double	   digested	  
with	   Eco0109I	   and	   Ahdl	   in	   order	   to	   eliminate	   de	   bla	   gene.	   The	   5´-­‐3´polymerase	   and	   the	   3´-­‐
5´exonuclease	  activities	  of	  the	  DNA	  Polymerase	  I	  (Large)	  Klenow	  Fragment	  was	  used	  in	  order	  to	  
end-­‐removal	  and	  fill-­‐in	  terminal	  unpaired	  nucleotides.	  
The	  blunting	  DNA	   reaction,	   composed	  of	   the	  digested	  vector	  about	  0.5	  mg,	  1	  μL	  of	  dNTPS	  25	  
mM	  (Bioline)	  and	  1	  μL	  of	  DNA	  polymerase	  I	  (5U/μL)	  (NEB),	  was	  incubated	  at	  room	  temperature	  
(RT)	  for	  20	  min,	  followed	  by	  a	  heat	  inactivation	  step	  at	  75	  °C	  for	  10	  min.	  The	  ligation	  reaction	  of	  
the	  blunt	  ended	  DNA	  fragments	  and	  corresponding	  plasmid	  backbones	  was	  carried	  out	  at	  16	  °C	  
overnight	   using	   T4	   ligase.	   The	   resulting	   ligation	   reaction	   vector	   was	   transformed	   into	   E.	   coli	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M15ΔglyA	  and	  plated	  on	  defined	  medium	  (DM)	  plates.	  Transformants	  were	  isolated	  and	  tested	  
both	   in	   DM	   and	   LB	   plus	   ampicillin	   plates,	   for	   positive	   and	   negative	   control,	   respectively.	  
Transformants	  were	  selected	  as	  being	  able	  to	  grow	  in	  defined	  media	  plates	  but	  not	  in	  LB	  plates	  
plus	  ampicillin	  and	  validated	  as	  described	  in	  section	  2.2.	  The	  best	  clone	  in	  terms	  of	  growth	  and	  
FucA	  production	  was	  selected	  through	  a	  screening	  process	  in	  500	  mL	  Shake	  Flasks	  with	  100	  mL	  
of	   defined	   media	   for	   triplicate	   (data	   not	   shown).	   The	   induction	   was	   performed	   at	   the	  
exponential	  phase	  with	  a	  pulse	  of	  1	  mM	  IPTG	  and	  the	  induction	  was	  maintained	  for	  4	  hours.	  	  
	  
	  
2.4 Culture	  media	  
Luria	  Bertani	   (LB)	  medium,	   containing	  10	  g·∙L-­‐1	  peptone,	  5	  g·∙L-­‐1	   yeast	  extract	  and	  10	  g·∙L-­‐1	  NaCl,	  
was	  used	  for	  pre-­‐cultures.	  
	  
The	  Defined	  Medium	  (DM)	  used	  for	  shake	  flasks	  cultures	  and	  for	   the	  agar	  plate	  contained	  per	  
liter:	   5	   g	   glucose,	   2.97	   g	   K2HPO4,	   0.60	   g	   KH2PO4,	   0.46	   g	   NaCl,	   0.75	   g	   (NH4)2SO4,	   0.11	   g	  
MgSO4·∙7H2O,	   0.006	   g	   FeCl3,	   0.025	   g	   thiamine,	   1.44	   g	   CaCl2·∙2H2O,	   0.07	  mL·∙100mL-­‐1	  medium	  of	  
trace	  elements	  solution	  (TES)	  (TES	  contained	  per	  liter:	  0.04	  g	  AlCl3·∙6H2O,	  1.74	  g	  ZnSO4·∙7H2O,	  0.16	  
g	   CoCl2·∙6H2O,	   2.18	   g	   CuSO4·∙5H2O,	   0.01	   g	  H3BO3,	   1.42	   g	  MnCl2·∙6H2O,	   0.01	   g	  NiCl2·∙6H2O,	   0.23	   g	  
Na2MoO4·∙5H2O).	  
	  
Stock	  solutions	  of	  kanamycin	  and	  chloramphenicol	  were	  prepared	  with	  a	  concentration	  of	  100	  
mg·∙mL-­‐1	  and	  30	  mg·∙mL-­‐1,	  respectively,	  and	  stored	  at	  -­‐20	  °C.	  Ampicillin	  100	  mg·∙L-­‐1	  ethanol	  stock	  
was	  prepared	  and	  stored	  at	  -­‐20	  °C.	  IPTG	  stock	  was	  prepared	  at	  100	  mM,	  and	  stored	  at	  -­‐20	  °C.	  
	  
Vitamins,	   antibiotics,	   TES,	   FeCl3,	   MgSO4·∙4H2O,	   CaCl2·∙2H2O	   and	   inducer	   were	   sterilized	   by	  
filtration	   (0.2	  µm	  syringe	   filter	  made	   from	  a	  blend	  of	   cellulose	   esters,	   Sartorius).	  Glucose	   and	  
saline	  solutions	  were	  separately	  sterilized	  by	  autoclaving	  at	  121°C	  for	  30	  min.	  
	  
	  
2.5 Cultivation	  conditions	  
Pre-­‐inoculum.	  From	  cryo-­‐stock	  stored	  at	  -­‐80°C,	  strains	  were	  grown	  in	  Falcon	  tubes	  with	  15	  mL	  of	  
LB	  medium,	  and	  supplemented	  with	  the	  corresponding	  antibiotic	  (ampicillin	  and	  kanamycin	  final	  
concentration	   100	   mg·∙L-­‐1,	   chloramphenicol	   30	   mg·∙L-­‐1).	   For	   the	   strain	   pQE-­‐FucA_puzzle	  
(J23110)_AmpR−	   no	   antibiotic	   was	   added.	   Growth	   was	   performed	   overnight	   at	   37	   °C	   with	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agitation,	  and	  after	  around	  16	  h	  of	  incubation,	  cultures	  reached	  2.0-­‐2.5	  units	  of	  optical	  density	  
at	  600	  nm	  (OD600).	  
	  
Inoculum.	  3	  mL	  of	  the	  overnight	  pre-­‐inoculum	  were	  transferred	  to	  a	  shake	  flask	  containing	  100	  
mL	   of	   DM,	   with	   the	   same	   growing	   conditions	   as	   pre-­‐inoculum	   cultures.	   All	   cultivations	   were	  
performed	  in	  a	  working	  volume	  of	  100	  mL	  in	  250	  mL-­‐volume	  baffled	  shake	  flasks.	  	  
To	   induce	   fucA	  expression,	  an	   IPTG	  pulse	  with	  a	  concentration	  of	  1	  mM	  was	  carried	  out.	  Cells	  
were	   induced	   when	   reached	   an	   OD600	   of	   1.5	   and	   the	   induction	   was	   maintained	   for	   4	   hours,	  
sampling	  before	  induction	  and	  after	  1,	  2	  and	  4	  hours	  of	  induction.	  	  
	  
	  
2.6 Analytical	  methods	  	  	  
Cell	   concentration	  was	   determined	   by	   optical	   density	   (OD)	  measurements	   at	   600	   nm	   using	   a	  
spectrophotometer	   (Uvicon	   941	   Plus,	   Kontrol).	   OD	   values	   were	   converted	   to	   biomass	  
concentration	  expressed	  as	  Dry	  Cell	  Weight	  (DCW),	  with	  1	  OD600	  equivalent	  to	  0.3	  gDCW·∙L-­‐1	  (24).	  	  
	  
For	  analysis	  of	  substrate	  and	  by-­‐products	  concentration	  in	  the	  cultivation	  broth,	  one	  milliliter	  of	  
culture	  medium	  was	  separated	  from	  biomass	  by	  centrifugation	  at	  maximum	  rpm	  for	  6	  min	  and	  
filtered	   (0.45	   µm	   membrane	   filter	   of	   cellulose	   esters,	   Millipore)	   prior	   to	   analysis.	   Glucose	  
concentration	   was	   determined	   enzymatically	   on	   an	   YSI	   2070	   system	   (Yellow	   Spring	   System).	  
Acetic	   acid	  was	   analyzed	   by	  HPLC	   (Hewlett	   Paackard	   1050)	   equipped	  with	   an	   ICSep	   COREGEL	  
87H3	   ICE-­‐99-­‐9861	   (Transgenomic)	   column	  and	  an	   IR	  detector	   (HP	  1047),	  using	  6	  M	  H2SO4	   (pH	  
2.0)	  as	  mobile	  phase,	  a	  flow	  rate	  of	  0.3	  ml·∙min-­‐1,	  at	  40	  °C.	  
The	  biomass	  yield,	  YX/S	  was	  calculated	  using	  the	  next	  equation:	  𝑌!/! = (𝐷𝐶𝑊!"# − 𝐷𝐶𝑊!)(𝐺𝑙𝑐! − 𝐺𝑙𝑐) 	  
where	  DCWmax	  and	  DCW0	  (g·∙L-­‐1)	  are	  the	  maximum	  and	  the	  initial	  biomass	  value,	  and	  the	  Glc0	  and	  
Glcf	  (g·∙L-­‐1)	  are	  the	  initial	  and	  the	  final	  value	  of	  glucose	  concentration,	  respectively.	  
The	  specific	  substrate	  uptake	  rate,	  qS,	  is	  defined	  as	  follows:	  𝑞! = 𝜇𝑌!/!	  
where	  qS	  is	  given	  as	  grams	  of	  carbon	  per	  grams	  of	  biomass	  per	  hour	  (g·∙g-­‐1DCW·∙h-­‐1).	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2.7 Enzyme	  activity	  for	  FucA	  
Samples	   from	   culture	   broths	  were	  withdrawn,	   adjusted	   to	   a	   final	  OD600	   of	   3,	   centrifuged	   and	  
then	   processed	   as	   previously	   described	   (25)(17).	   Briefly,	   after	   rejecting	   the	   supernatant,	   the	  
pellets	   were	   resuspended	   in	   100	   mM	   TrisHcl	   (pH	   7.5)	   keeping	   the	   same	   OD600	   previously	  
adjusted.	  Cell	  suspensions	  were	  placed	  in	  ice	  and	  sonicated	  with	  four	  15	  seconds	  pulses	  at	  50W	  
with	  2	  minutes	   intervals	   in	   ice	  between	  each	  pulse,	   using	  a	  VibracellTM	  model	  VC50	   (Sonics	  &	  
Materials).	  Cellular	  debris	  was	   then	   removed	  by	   centrifugation	  and	   the	   clear	   supernatant	  was	  
collected	  for	  product	  analysis.	  
Two	   different	  methods	   were	   used	   to	   quantify	   the	   product	   in	   each	   sample.	   One	  was	   used	   to	  
calculate	   the	   FucA	   activity	   while	   the	   second	   one	   was	   used	   to	   quantify	   the	   amount	   of	   FucA	  
amongst	  the	  rest	  of	  intracellular	  soluble	  proteins	  (17).	  One	  unit	  of	  FucA	  activity	  is	  defined	  as	  the	  
amount	   of	   enzyme	   required	   to	   convert	   1	   μmol	   of	   fuculose-­‐1-­‐phosphate	   in	   DHAP	   and	   L-­‐
lactaldehyde	  for	  minute	  at	  25	  °C	  and	  pH	  7.5.	  
	  
For	   all	   the	   results,	   average	   values	   were	   plotted	   with	   error	   bars.	   The	   error	   indicates	   the	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3 Results	  
	  
3.1 Comparison	  of	  FucA	  expression	  between	  M15[pREP4]	  and	  M15[pREP4]	  ΔglyA	  strain	  
A	  first	  stage	  performance,	  the	  reference	  FucA	  expression	  systems	  E.	  coli	  M15[pREP4]	  pQE-­‐FucA	  
and	  E.	  coli	  M15ΔglyA[pREP4]	  pQEαβFucA	  was	  assessed	  in	  shake	  flasks	  cultures	  in	  defined	  media	  
(DM).	  Heterologous	  expression	  was	  induced	  in	  mid-­‐	  exponential	  phase	  cultures	  using	  1mM	  IPTG	  
in	   order	   to	   compare	   biomass,	   FucA	   and	   acetate	   production,	   as	   well	   as	   glucose	   consumption	  
profile	   along	   time	   (Figure.	   5).	  As	   it	   can	  be	   seen	   in	   figures	   5A	  and	  5B,	   cell	   growth	   slows	  down	  
after	  IPTG	  induction	  and	  even	  starts	  declining	  in	  the	  M15ΔglyA	  strain.	  The	  reference	  M15	  strain	  
presents	  a	   slightly	  higher	  maximum	  specific	   growth	   rate	   (μmax)	  of	  0.49	  ±	  0.01	  h-­‐1	   compared	   to	  
0.44	   ±	   0.01	   h-­‐1	  of	   the	  M15ΔglyA.	   This	   effect	  may	   be	   caused	   by	   the	   increase	   in	   the	  metabolic	  
burden	  due	  to	  expression	  vector	  maintenance	  in	  the	  M15ΔglyA	  strain.	  	  
	  
	  Fig.	   5	   (¢)	   Biomass	   DCW	   (g·∙L-­‐1),(	   )	   enzyme	   activity	   (AU·∙gDCW-­‐1),	   (n)specific	   mass	   production	   content	  
(mgFucA·∙gDCW-­‐1),	   	   ( )	  Glucose	   (g·∙L-­‐1)	  and	   (	   )	  Acetic	  Acid	   (g·∙L-­‐1)	  profiles	  along	   time	   in	  a	  defined	  medium.	  The	  
arrow	  indicates	  the	  IPTG	  pulse	  for	  the	  induction.	  A	  and	  C	  refer	  to	  the	  M15[pREP4]	  pQE-­‐FucA	  strain	  while	  B	  and	  D	  
refer	   to	   the	  M15ΔglyA[pREP4]	  pQEαβFucA	  strain.	  Shake	   flasks	  cultures	  were	  performed	  by	   triplicate,	  at	  37°C	   in	  
agitation.	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Substrate	  uptake	  rates,	  qS,	  along	  the	  induction	  phase	  for	  both	  strains	  were	  calculated	  being	  0.37	  
±	  0.04	  and	  0.50	  ±	  0.13	  gGlc·∙g-­‐1DCW·∙h-­‐1	  for	  the	  M15	  and	  for	  the	  M15	  ΔglyA[pREP4],	  respectively.	  
As	   a	   consequence,	   the	   M15	   ΔglyA[pREP4]	   strain	   accumulated	   higher	   amounts	   of	   acetate	  
throughout	  the	  growth	  process,	  reaching	  	  a	  final	  concentration	  of	  0.54	  ±	  0.03	  g·∙L-­‐1	  as	   it	  can	  be	  
observed	   in	   figure	   5D.	   The	   physiological	   background	   for	   this	   acid	   production	   under	   aerobic	  
conditions	  has	  been	  found	  to	  be	  a	  result	  of	  unbalanced	  rates	  of	  glycolysis	  and	  the	  oxidation	  of	  
the	   metabolites	   formed	   due	   to	   saturation	   of	   this	   respiration	   capacity	   of	   E.	   coli	   (26).	  
Furthermore,	   it	   has	   been	   reported,	   that	   the	   recombinant	   protein	   production	   is	   significantly	  
reduced	   by	   acetate	   accumulation	   (27).	   Accordingly,	   both	   FucA	   activity	   (AU·∙g-­‐1	  DCW)	   and	   FucA	  
mass	  (mg·∙g-­‐1DCW)	  (Figure	  5B)	  decrease	  more	  than	  50%	  comparing	  the	  M15ΔglyA	  strain	  to	  the	  
reference	  M15	  system	  (Figure	  5A).	  Whereas	  the	  M15	  strain	  reached	  a	  final	  production	  of	  181	  ±	  
5	  mgFucA·∙g-­‐1DCW,	  with	  an	  activity	  of	  721	  ±	  82	  AU·∙g-­‐1DCW,	  these	  values	  were	  reduced	  to	  67	  ±	  37	  
mgFucA·∙g-­‐1DCW	  291	   ±	   24	   AU·∙g-­‐1DCW	   respectively,	   in	   the	  M15ΔglyA	   strain.	   The	   results	   shown	  
above	  could	  be	  related	  to	  the	  concomitant	  SHMT	  overexpression	  observed	  after	  induction	  in	  the	  
M15ΔglyA	   strain.	   This	   fact	   could	   impose	   a	   slight	   metabolic	   burden	   to	   the	   cell,	   i.e.	   having	   a	  
negative	  impact	  on	  the	  μmax	  and	  FucA	  production.	  	  
Noteworthy,	  the	  metabolic	  burden	  is	  caused	  not	  only	  due	  to	  the	  overexpression	  of	  the	  protein	  
of	   interest	  but	  also	   to	   the	  expression	  of	  other	  plasmid-­‐encoded	  genes,	  e.g.	   the	  glyA	  may	  also	  
contribute	  (19).	  	  
The	  above	  statement	  is	  in	  agreement	  with	  significant	  amounts	  of	  SHMT	  accumulated	  as	  soluble	  
protein	   in	   the	   cytoplasm	   of	   M15ΔglyA[pREP4]	   pQEαβFucA	   cells,	   as	   observed	   in	   SDS-­‐PAGE	  
analysis	   (Figure	   6).	   This	   suggests	   that	   overexpression	   of	   the	  multicopy	   plasmid-­‐encoded	   glyA	  
gene	   leads	   to	   substantially	   higher	   amounts	   of	   SHMT,	   compared	   to	   the	   reference	   strain	  
containing	  a	  single	  copy	  of	  this	  gene	  in	  its	  genome,	  thereby	  imposing	  a	  significant	  burden	  to	  the	  
cell’s	   metabolism	   and	   affecting	   negatively	   the	   expression	   of	   FucA.	   Overall,	   these	   first	   results	  
pointed	  at	  the	  regulation	  of	  the	  glyA	  expression	   levels	  as	  an	   important	  parameter	  to	  be	  taken	  
into	  account	  for	  further	  improvement	  of	  the	  expression	  system.	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  Fig.	  6	  SDS-­‐PAGE	  of	  shake	  flasks	  culture’s	  samples.	  A)	  Triplicate	  of	  the	  M15[pREP4]/pQE-­‐FucA	  strain;	  B)	  Triplicate	  
of	   the	  M15ΔglyA[pREP4]/pQEαβFucA	  strain.	   Lane	  M:	  molecular	  weight	  marker.	  1,	  2,	  3	  correspond	   to	   the	  shake	  
flask	  culture	  replicates	  while	  the	  PI	  (pre	  induction)	  and	  1	  h,	  2h	  and	  4h	  correspond	  to	  the	  time	  after	  induction.	  	  The	  
26	  kDa	  FucA	  and	  46	  kDa	  SHMT	  bands	  are	  indicated	  in	  the	  figure	  with	  arrows.	  
	  
	  
3.2 Single	  plasmid	  expression	  system	  
The	   regulation	   of	  glyA	   expression	   levels	   has	   a	   key	   role	   in	   improving	   the	   recombinant	   protein	  
production,	  as	  mentioned	  before.	  In	  addition,	  in	  order	  to	  decrease	  the	  extent	  of	  the	  metabolic	  
load	   and	   in	  order	   to	  obtain	   an	  expression	   system	  completely	   antibiotic	   free-­‐plasmid	   selection	  
system,	   we	   focused	   on	   pREP4	   plasmid	   elimination.	   The	   objectives	   were	   to	   i)	   obtain	   an	  
expression	  system	  based	  on	  a	  single	  plasmid;	  ii)	  clone	  the	   lacI	  gene	  from	  the	  pREP4	  plasmid	  to	  
the	  pQE-­‐expression	  vector;	  and	  iii)	  tune	  the	  glyA	  expression	  levels.	  	  
Accordingly,	   the	  pREP4	  plasmid	  was	  eliminated	   from	   the	  M15ΔglyA	   [pREP4]	  pQEαβFucA	   cells,	  
obtaining	   the	   new	   strain	   M15ΔglyA	   pQEαβFucA.	   Shake	   flasks	   cultures	   were	   performed	   in	  
defined	  media	   supplemented	  with	   ampicillin	   (data	   not	   shown).	   An	   increase	   in	   the	   basal	   FucA	  
production	  was	  expected,	  due	  to	  the	  removal	  of	  the	  repressor	  protein	  encoded	  by	  the	  lacI	  gene	  
present	  on	  the	  pREP4	  plasmid.	  Strikingly,	  no	  FucA	  production	  was	  detected	  in	  these	  cultures.	  To	  
further	  understand	  this	  effect,	  the	   lacI	  gene	  from	  the	  pREP4	  was	  amplified	  and	  cloned	  into	  the	  
pQEαβFucA	   plasmid,	   obtaining	   the	   pQE-­‐lacI-­‐αβFucA	   expression	   vector.	   Again,	   shake	   flasks	  
cultures	   were	   performed	  with	  M15ΔglyA	   strain	   harboring	   this	   plasmid	   (data	   not	   shown),	   but	  
FucA	   expression	   could	   neither	   be	   detected.	   In	   order	   to	   ensure	   there	   was	   no	   loss	   of	   the	  
expression	  vector	  from	  the	  cells,	  the	  plasmid	  segregational	  stability	  was	  carried	  out	  at	  different	  
cultivation	   times	  before	  and	  after	   induction.	  Also,	  M15ΔglyA	  pQE-­‐lacI-­‐αβFucA	  growth	  on	  both	  
LB	  and	  LB-­‐ampicillin	  agar	  plates	  was	  tested.	  Both	  series	  of	  experiments	  confirmed	  that	  the	  cells	  
maintained	   the	  expression	   vector	   and,	   consequently,	   the	   lack	  of	   FucA	  expression	  was	   not	   the	  
result	  of	  plasmid	  loss.	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A	  possible	  explanation	  for	  the	   lack	  of	  FucA	  expression	   in	  the	  system	  with	  no	   lacI	  gene	  may	  be	  
related	   to	   T5	   promoter	   leakiness	   in	   absence	   of	   lacI	   repressor,	   leading	   to	   plasmid	   structural	  
instability,	  as	  discussed	  in	  section	  3.3.	  Alternatively,	  a	  possible	  explanation	  for	  the	  lack	  of	  FucA	  
expression	  in	  the	  single	  plasmid	  system	  may	  be	  that	  the	  copy	  number	  of	  the	  lacI	  gene	  increases	  
when	  cloned	  into	  the	  pQE-­‐	  vector,	  resulting	  in	  significantly	  higher	  lacI	  intracellular	  levels.	  In	  fact,	  
the	  pQE	  vector	  is	  based	  on	  the	  plasmid	  ColE1	  replication	  origin,	  which	  presents	  a	  copy	  number	  
2-­‐fold	  higher	  compared	  with	  the	  P15A	  replicon	  of	  the	  pREP4	  (1).	  	  
Overall,	   these	   experiments	   confirmed	   the	   need	   for	   tuning	   the	   lacI	   transcriptional	   levels	   for	  
optimal	  regulation	  and	  induction	  of	  the	  foreign	  gene	  expression	  when	  re-­‐locating	  different	  parts	  
of	  the	  reference	  two-­‐plasmid	  system	  into	  a	  single	  plasmid.	  
	  
	  
3.3 Tuning	  of	  lacI	  and	  glyA	  expression	  levels	  
As	  mentioned	  in	  the	  materials	  and	  methods	  section,	  the	  T5	  promoter	  has	  a	  double	  lac	  O	  region	  
in	   order	   to	   guarantee	   a	   strong	   repression	   under	   non-­‐induction	   conditions.	   The	   lac	   repressor,	  
encoded	  by	  the	  lacI	  gene,	  binds	  very	  tightly	  to	  the	  promoter	  and	  ensures	  efficient	  repression	  of	  
the	   strong	   T5	   promoter	   interfering	   with	   the	   transcription	   of	   the	   gene	   of	   interest.	   As	   stated	  
above,	  promoter	   leakiness	   in	  repressor	  absence	  might	  have	   lead	  to	  structural	   instability	  of	  the	  
expression	  vector,	  resulting	  in	  reduced	  expression	  levels.	  To	  test	  this	  hypothesis,	  we	  sequenced	  
the	  T5	  promoter	  region	  isolated	  from	  several	  non-­‐producing	  M15ΔglyA	  pQEαβFucA	  constructs.	  
Notably,	  we	  observed	  a	  deletion	  in	  the	  lac	  O	  regions,	  probably	  due	  to	  recombination	  events	  of	  
the	  homology	  region	  (data	  not	  shown).	  
This	   further	   confirmed	   the	   relevance	   of	   lacI	   transcriptional	   levels	   as	   key	   parameter	   in	   T5	  
promoter-­‐based	   expression	   systems,	   influencing	   both	   the	   basal	   and	   induced	   transcriptional	  
levels.	   For	   this	   reason,	   a	   series	   of	   FucA	   expressing	   strains	   presenting	   4	   different	   constitutive	  
transcriptional	   levels	  of	   lacI	  have	  been	  constructed	  as	  described	  in	  the	  Materials	  and	  Methods	  
section	   (Figure.	   1A).	   A	   set	   of	   4	   calibrated	   promoters	   covering	   a	  wide	   range	   of	   transcriptional	  
efficiencies	   has	   been	   used.	   Moreover,	   because	   the	   first	   generation	   of	   the	   glyA-­‐based	  
auxotrophic	  plasmid	  maintenance	  system	  contained	  the	  glyA	  gene	  under	  the	  control	  of	  the	  P3	  
constitutive	   promoter,	   resulting	   in	   relatively	   high	   amounts	   of	   its	   product,	   the	   same	   set	   of	   4	  
promoters	  has	  also	  been	  tested	  to	  reduce	  the	  transcriptional	  levels	  of	  the	  glyA	  gene	  (Vidal	  L	  et	  
al.,	   2008).	   Thus,	   an	   expression	   cassette	  was	   settled	  where	   the	   lacI	   and	  glyA	   genes	  have	  been	  
placed	  under	  the	  control	  of	  a	  constitutive	  promoter.	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3.3.1 pSB1C3	  J231XX	  constructions	  
In	  this	  study,	  the	  BioBrick	  vector	  pSB1C3	  was	  used	  as	  template	  for	  the	  construction	  of	  a	  series	  of	  
four	   vectors,	   each	   co-­‐expressing	   the	  glyA	   and	   lacI	   genes	   under	   the	   four	   selected	   constitutive	  
promoters.	   That	   is,	   each	   expression	   vector	   differs	   from	   the	   other	   just	   for	   the	   constitutive	  
promoters.	   The	   aim	  was	   to	   find	   the	   promoter	  with	   enough	   activity	   to	   produce	   the	  minimum	  
amount	   of	   LacI	   inhibitor	   preventing	   “promoter	   leakiness”,	   as	   well	   as	   the	   minimal	   glyA	  
transcriptional	  levels	  needed	  for	  plasmid	  maintenance	  and	  optimal	  cell	  growth	  in	  defined	  media.	  	  
This	  plasmid	  series	  was	  assembled	  using	  a	  Golden	  Gate-­‐based	  strategy.	  In	  particular,	  the	  pSB1C3	  
(Figure.	  7),	   a	  high	  copy	  BioBrick	  assembly	  plasmid,	  was	  prepared	  by	  means	  of	  a	  PCR	   reaction,	  
introducing	   two	  BsaI	   restrictions	   sites	   with	   the	   two	   different	   overhangs.	   Both	   the	   replication	  
origin	  and	  the	  antibiotic	  resistance	  marker	  were	  maintained	  as	  standard	  parts.	  	  
	  
	  Fig.	  7	  pSB1C3	  vector	  with	  the	  2	  BsaI	  restriction	  sites.	  In	  pink	  the	  mCherry	  gene,	  in	  yellow	  the	  
replication	  origin	  (pMB1)	  and	  in	  light	  blue	  the	  chloramphenicol	  resistance	  gene	  (CamR).	  
	  
Both	  the	  lacI	  and	  glyA	  genes	  were	  also	  prepared	  as	  PCR	  products	  and	  kept	  as	  standard	  parts	  of	  
the	  BioBrick	  vectors.	  The	  lacI	  gene	  was	  amplified	  by	  PCR	  from	  the	  pREP4	  plasmid	  introducing	  de	  
novo	  a	  strong	  RBS	  sequence	  (BBa_B0034,	  http://parts.igem.org/Part:BBa_B0034).	  The	  DNA	  part	  
containing	   the	   glyA	   gene	   was	   obtained	   by	   PCR	   reaction	   from	   the	   pQEαβRham	   plasmid	  
comprised	   with	   a	   strong	   RBS	   sequence	   (BBa_J61100,	   http://parts.igem.org/Part:BBa_J61100),	  
i.e.	   different	   from	   the	   one	   for	   lacI	   gene	   in	   order	   to	   avoid	   homologous	   recombination.	   As	  
terminator	   sequence	   we	   maintained	   the	   glyA	   own	   terminator	   region,	   amplified	   from	  
chromosomal	  E.	  coli	  K-­‐12	  (17).	  For	  both,	  genes	  and	  promoters	  were	  introduced	  at	  the	  5’	  and	  3’	  
terminus	  the	  BsaI	  site	  with	  two	  overhangs	  (Fig	  8A).	  Remarkably,	  all	  golden	  gate	  DNA	  fragments	  
were	   designed	   with	   different	   overhangs	   bases	   in	   order	   to	   have	   directional	   cloning	   and	   to	  
prevent	  the	  relegation	  of	  empty	  vector	  (Figure.	  8B).	  Thus,	  reactions	  could	  be	  performed	  in	  one-­‐
step	   restriction-­‐ligation,	   as	   illustrated	   in	   Figure	   3B.	   The	   final	   constructs	  were	   named	   pSB1C3-­‐
J23XX,	  where	  the	  “X”	  corresponds	  to	  the	  name	  of	  the	  promoter	  used	  (Fig.	  8C).	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  Fig.	   8	  Golden	  Gate	  Assembly	  Method.	  A)	  PCR	  products	  of	  the	  promoters	  (J231XX)	  and	  the	   lacI	  and	  glyA	  genes	  
with	   the	   different	   overhangs	   of	   the	   BsaI	   at	   the	   5’	   and	   3’	   terminus	   in	   different	   colors	   showing	   the	  
complementary	   part	   for	   the	   directional	   cloning.	   B)	   Schematic	   diagram	   of	   Golden	   Gate	   assembly	   method	   to	  
facilitate	  the	  construction	  of	  the	  new	  BioBrick	  vectors.	  C)	  Representation	  of	  the	  four	  pSB-­‐J231XX	  vectors,	  each	  
one	  with	  one	  of	  the	  four	  constitutive	  promoters.	  	  
	  
Once	  obtained	  the	  four	  expression	  vectors,	  they	  were	  transformed	  together	  with	  the	  pQE-­‐FucA	  
plasmid	   into	  M15ΔglyA.	   The	   resulting	   final	   strains	   were	   named	  M15ΔglyA	   pQE-­‐40	   +	   pSB1C3-­‐
J231XX.	  To	  demonstrate	  the	  correct	  assembly	  of	  BioBrick	  parts	  into	  the	  new	  expression	  vectors,	  
colony	  PCR	  was	  performed	  for	  at	  least	  6	  white	  transformants	  for	  each	  construction.	  Finally,	  one	  
correct	   assembled	   clone	   for	   each	   strain	   was	   selected	   for	   further	   testing	   in	   expression	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3.4 Small	  scale	  expression	  experiments	  with	  the	  BioBrick	  constructs	  
The	  over-­‐expression	  of	  FucA	  for	   the	  4	  resulting	  selected	  transformants	  was	  tested	   in	   triplicate	  
shake	   flasks	   cultures,	   in	   which	   biomass,	   glucose	   consumption	   and	   enzyme	   production	   was	  
analyzed	   along	   time	   (Figure	   9).	   The	   cultures	   were	   grown	   on	   5	   g·∙L-­‐1	   of	   initial	   glucose	  
concentration	  and	  when	  the	  OD	  reached	  1.5,	  FucA	  expression	  was	  induced	  with	  1	  mM	  of	  IPTG.	  
Culture	   samples	   were	   collected	   before	   induction	   and,	   1	   h	   and	   2h	   post-­‐induction	   for	   further	  
analysis.	  	  The	  evolution	  of	  cultures	  is	  summarized	  in	  figure	  9.	  	  	  
	  
	  	  Fig.	   9.	   Shake	   flask	   cultures	   of	  M15ΔglyA	   pQE-­‐FucA	   pSB1XX	   strains	   series.	   (¢)	   Biomass	   DCW(g·∙L-­‐1),	   (	   )	   enzyme	  
activity	  (AU·∙g-­‐1DCW)	  and	  (n)specific	  mass	  production	  (mgFucA·∙g-­‐1DCW)	  profiles	  along	  time	  in	  a	  defined	  media	  shake	  
flasks	  cultures	  performed	  for	  the	  4	  different	  selected	  transformants,	  that	  is,	  M15ΔglyA	  pQE-­‐FucA	  pSB1C3	  with	  the	  4	  
different	  constitutive	  promoters:	  A)	  J23100	  B)	  J23111	  C)	  J23110	  D)	  J23117.	  The	  arrow	  indicates	  the	  IPTG	  pulse	  for	  the	  
induction.	  	  
The	  specific	  growth	  rate	  measured	  in	  the	  different	  cultures	  showed	  a	  similar	  behavior	  for	  all	  the	  
transformants	   except	   for	   those	   with	   the	   J23100	   promoter,	   which	   presented	   a	   μmax	   1.3	   fold	  
higher	  than	  the	  reference	  strain	  M15	  and	  than	  the	  rest	  of	  strains	  (Table	  3).	  Conversely,	  the	  use	  
of	   a	   stronger	   promoter	   for	   the	   lacI	   and	   glyA	   expression	   such	   as	   the	   J23100	   resulted	   in	   low	  
detection	  levels	  of	  FucA,	  both	  in	  terms	  of	  mass	  and	  activity.	  This	  observation	  can	  be	  related	  to	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the	  previous	  results	  (Section	  3.2).	  Therefore,	  a	  higher	  growth	  rate	  could	  be	  explained	  as	  follows:	  
higher	   constitutive	   lacI	   expression	   level	   may	   lead	   to	   a	   reduction	   of	   the	   fucA	   expression	   and	  
subsequently	  to	  the	  decrease	  of	  the	  metabolic	  burden.	  	  	  Table	  3	  Maximum	  specific	  growth	  rate	  (μmax	  h-­‐1),	  FucA	  activity	  (AU·∙g-­‐1DCW),	  FucA	  mass	  (mg·∙g-­‐1DCW),	  qS	  of	  the	  
induction	   phase	   and	   the	   maximum	   acetate	   yield	   (g·∙g-­‐1DCW)	   for	   each	   of	   the	   fours	   selected	   transformants	  
M15ΔglyA	  pQE-­‐FucA	  pSB1C3	  with	  the	  4	  different	  constitutive	  promoters:	  J23100,	  J23111,	  J23110	  and	  J23117.	  
The	  values	  represent	  the	  sample	  after	  2	  hour	  of	  induction.	  
Promoter	   μmax	  (h-­‐1)	  
FucA	  Activity	  
(AU·∙g-­‐1DCW)	  
FucA	  mass	  	  	  	  	  	  	  	  	  
(mg·∙g-­‐1DCW)	  




J23100	   0.62	  ±	  0.05	   131	  ±	  35	   22	  ±	  9	   0.79	  ±	  0.10	   1.5	  ±	  0.10	  
J23111	   0.37	  ±	  0.01	   233	  ±	  7	   66	  ±	  4	   0.42	  ±	  0.09	   1.12	  ±	  0.09	  
J23110	   0.48	  ±	  0.01	   574	  ±	  49	   83	  ±	  7	   0.44	  ±	  0.06	   0.70	  ±	  0.12	  
J23117	   0.41	  ±	  0.01	   194	  ±	  24	   50	  ±	  5	   0.58	  ±	  0.01	   1.11	  ±	  0.05	  
	  
	  
As	  it	  can	  be	  seen	  in	  figure	  9C	  and	  in	  table	  3,	  the	  best	  expression	  vector	  is	  the	  one	  harboring	  the	  
constitutive	  promoter	  J23110,	  which	  is	  in	  the	  lower	  range	  of	  tested	  lacI	  and	  glyA	  transcriptional	  
levels	  (Figure	  1A).	  This	  suggested	  that	  the	  reduced	  lacI	  and	  glyA	  genes	  expression	  seems	  to	  have	  
reduced	   the	   energy	   and	   building	   blocks	   demand	   for	   glyA	   synthesis,	   as	   well	   as	  minimizing	   T5	  
promoter	   leakiness,	   resulting	   in	   an	   overall	   reduced	  metabolic	   burden,	   as	   reflected	   in	   the	   fact	  
that	   the	  μmax	  of	   this	  strain	  under	  pre-­‐induction	  conditions	  was	  comparable	   to	   that	  of	   the	  M15	  
reference	  strain	  (0.48	  ±	  0.01	  h-­‐1).	  
Furthermore,	  when	  looking	  at	  the	  glucose	  consumption	  profile	  (Fig	  10)	  it	  can	  be	  observed	  that	  
the	  4	  different	  constructs	  have	  a	   similar	   trend	  during	   the	  exponential	  phase,	  while	   comparing	  
the	  qS	  values	  during	  the	  induction	  phase	  it	  can	  be	  clearly	  seen	  that	  the	  “J23100”	  strain	  is	  the	  one	  
with	  higher	  specific	  uptake	  rate	  of	  glucose	  (Table	  3).	  Coherently	  this	  strain	   is	  the	  one	  with	  the	  
highest	  yield	  of	  acetate	  reaching	  1.50	  ±	  0.10	  gAc·∙g-­‐1DCW.	  
Concerning	  the	  best	  expression	  vector	  J23110:	   it	   is	   the	  one	  that	  present	  the	   lowest	  qS	  (0.44	  ±	  
0.06	  g·∙g-­‐1DCW·∙h-­‐1)	  and	  acetate	  yield	  (0.70	  ±	  0.12	  g·∙g-­‐1DCW)	  comparing	  with	  the	  other	  constructs.	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  Fig.	   10	   ( )	   Glucose	   (g·∙L-­‐1)	   and	   ( )	   Acetic	   Acid	   (g·∙L-­‐1)	   profiles	   along	   time	   in	   a	   defined	  media	   shake	   flasks	   cultures	  
performed	   at	   37°C	   150	   rpm	   for	   the	   4	   different	   selected	   transformants	   M15ΔglyA	   pQE-­‐FucA	   pSB1C3	   with	   the	   4	  
different	  constitutive	  promoters:	  A)	  J23100	  B)	  J23111	  C)	  J23110	  D)	  J23117.	  The	  arrow	  indicates	  the	  IPTG	  pulse	  for	  the	  
induction.	  
	  
3.5 M15ΔglyA	  pQE-­‐FucA_puzzle	  strain	  
Once	  selected	  M15ΔglyA	  pQE-­‐FucA	  +	  pSB1C3-­‐J23110	  as	  the	  strain	  with	  highest	  FucA	  production	  
and	  specific	  activity	  among	  the	  4	  different	  constructs,	  as	  well	  as	  being	  able	  to	  grow	  at	  the	  same	  
μmax	  as	   the	   reference	   strain	   (0.48	   ±	   0.01	   h-­‐1),	   our	   next	   goal	   was	   the	   construction	   of	   a	   single	  
expression	  vector	  harboring	  both	  the	  fucA	  gene	  under	  control	  of	  the	  inducible	  T5	  promoter	  and	  
the	   lacI-­‐glyA	   cassette	   cloned	   under	   the	   J23110	   constitutive	   promoter.	   Such	   plasmid	   was	  
constructed	   as	   described	   in	   Materials	   and	   Methods	   section	   and	   further	   transformed	   into	  
M15ΔglyA,	  yielding	  E.	  coli	  M15ΔglyA	  pQE-­‐FucA_puzzle	  (J23110).	  
Shake	   flask	   cultivations	   of	   the	   new	   strain	   were	   carried	   out	   in	   triplicate	   at	   37°C	   in	   defined	  
medium	   (DM)	   with	   5	   g·L-­‐1	   glucose	   as	   initial	   carbon	   source,	   without	   any	   antibiotic	  
supplementation.	  Again,	  cultures	  were	  induced	  at	  1mM	  of	  IPTG.	  The	  μmax	  of	  the	  M15ΔglyA	  pQE-­‐
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FucA_puzzle	   (J23110)	  was	   0.45	   ±	   0.01	  h-­‐1,	   comparable	   to	   those	   from	   the	  preceding	   2-­‐plasmid	  
construct	  and	  original	  reference	  strain	  (0.49∼0.48	  ±	  0.01	  h-­‐1).	  
	  
	  Fig.	   11	   A)	   (¢)	   Biomass	   DCW	   (g·∙L-­‐1),	   (	   )	   enzyme	   activity	   (AU·∙g-­‐1DCW),	   (n)specific	   mass	   content	  
(mgFucA·∙g-­‐1DCW)	  and	  B)	  ( )	  Glucose	  (g·∙L-­‐1)	  and	  (	   )	  Acetic	  Acid	  (g·∙L-­‐1)	  profiles,	  along	  time	  in	  a	  defined	  
medium	  shake	  flasks	  cultures	  performed	  at	  37°C	  for	  the	  M15ΔglyA	  pQE-­‐FucA_puzzle	  (J23110)	  strain.	  
The	  arrow	  indicates	  the	  1mM	  IPTG	  pulse	  for	  the	  induction.	  	  
	  
Maximum	  FucA	  mass	  and	  FucA	  specific	  activity	  reached	  were	  97	  ±	  14	  mg-­‐1	  FucA·∙g-­‐1DCW	  and	  984	  
±	  32	  AU·∙g-­‐1DCW,	   respectively	   (Figure	  11	  A).	  Comparing	   these	  values	  with	   those	  obtained	  with	  
the	  M15	  pQE-­‐FucA	  reference	  strain	  (181	  ±	  5	  mg	  FucA·∙g-­‐1	  DCW	  and	  721	  ±	  82	  AU·∙g-­‐1	  DCW),	  it	  can	  
be	   observed	   how,	   even	   though	   the	   amount	   of	   the	   recombinant	   protein	   was	   still	   lower,	   the	  
specific	  activity	  increased	  1.4-­‐fold.	  Besides,	  the	  M15ΔglyA	  pQE-­‐FucA_puzzle	  (J23110)	  presented	  
a	  reduction	  in	  the	  amount	  of	  acetate	  production,	  being	  0.57	  ±	  0.03	  g·∙g-­‐1DCW,	  relating	  to	  0.73	  ±	  
0.04	  g·∙g-­‐1DCW	  of	  the	  M15	  pQE-­‐FucA	  reference	  strain.	  	  
Overall,	   these	   results	   suggest	   that	   transcriptional	   tuning	   of	   lacI	   expression	   levels	   brings	   to	   a	  
better	  fucA	  expression	  regulation	  allowing	  for	  an	  extended	  production	  formation	  period,	  leading	  
to	  a	  higher	  FucA	  specific	  activity.	  Moreover,	  glyA	  levels	  also	  co-­‐down	  regulated,	  have	  a	  positive	  
effect	  on	  the	  reduction	  of	  the	  metabolic	  load	  due	  to	  expression	  of	  plasmid-­‐encoded	  genes	  (also	  
reflected	  in	  the	  reduced	  acetate	  production).	  	  
These	  results	  are	  in	  accordance	  with	  the	  observation	  of	  Mairhofer	  et	  al.	  (28),	  who	  demonstrated	  
that	   the	   folding	   apparatus	   is	   severely	   overstrained	   in	   the	   plasmid-­‐based	   expression	   system	  
compared	  with	  the	  plasmid-­‐free	  cells	  due	  to	  the	  different	  transcriptional	  profile.	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3.6 M15ΔglyA	  pQE-­‐FucA_puzzle_AmpR-­‐	  strain	  
Lastly,	  an	  expression	  system	  completely	  devoid	  of	  antibiotic	   resistance	  genes	  was	  constructed	  
by	  removing	  the	  bla	  gene	   from	  the	  expression	  vector.	  The	  corresponding	  strain	  was	  named	  E.	  
coli	   M15ΔglyA	   pQE-­‐FucA_puzzle	   (J23110)_AmpR-­‐.	   The	   ampicillin	   resistance	   gene	   (bla)	   was	  
eliminated	   from	   the	   pQE-­‐FucA_puzzle	   (J23110)	   plasmid	   using	   the	   Klenow	   fragment-­‐based	  








After	   a	   screening	   process	   (section	   2.3)	   the	   best	   clone	   in	   term	  of	   best	   growth	   rate	   and	  higher	  
recombinant	  protein	  production	  was	  selected	  (Data	  not	  shown).	  	  
As	  for	  the	  previous	  strains,	  shake	  flask	  cultures	  of	  the	  new	  strain	  were	  carried	  out	  in	  triplicate	  at	  
37°C	  in	  defined	  medium	  (DM)	  without	  any	  antibiotic	  supplementation.	  The	  time-­‐profiles	  of	  the	  
biomass,	  glucose	  consumption,	  acetate	  and	  FucA	  mass	  and	  FucA	  specific	  activity	  were	  analyzed	  
and	  represented	  in	  figure	  14.	  
	  
Fig.	  12	  Schematic	  diagram	  of	   the	  construction	  strategy	  of	  pQE-­‐FucA_puzzle	  (J23110)_AmpR−.	  A)	  Double	  digestion	  of	   pQE-­‐FucA_puzzle	   (J23110)	   vector	   by	   the	   restriction	   enzymes	  Eco0109I	   and	  AhdI.	  B)	  End	   removal	   and	   fill-­‐in	   of	   terminal	   unpaired	   nucleotides	  by	  DNA	  polymerase	   I	   (large)	  Klenow	  fragment	  (NEB).	  C)	  Final	  ligation	  obtaining	  pQE-­‐FucA_puzzle	  (J23110)_AmpR−	  expression	  vector.	  
	   26	  
	  	  Fig.	   13	  A)	   (¢)	   Biomass	   DCW(g·∙L-­‐1),	   (	   )	   enzyme	   activity	   (AU·∙g-­‐1DCW),	   (n)specific	  mass	  
(mgFucA·∙g-­‐1DCW)	  and	  B)	  ( )	  Glucose	  (g·∙L-­‐1)	  and	  (	   )	  Acetic	  Acid	  (g·∙L-­‐1)	  profiles,	  along	  time	  
in	  a	  defined	  medium	  shake	  flasks	  cultures	  performed	  at	  37°C	  150	  rpm	  for	  the	  M15ΔglyA	  
pQE-­‐FucA_puzzle	  (J23110)	  strain.	  The	  arrow	  indicates	  the	  IPTG	  pulse	  for	  the	  induction.	  
	  
A	   small	   but	   significant	   decrease	   can	   be	   observed	   in	   the	  μmax	   0.41	   ±	   0.01	   h-­‐1	   compared	   to	   the	  
strains	  M15[pREP4]	  pQE-­‐FucA	  and	  M15ΔglyA	  pQE-­‐FucA_puzzle	  (J23110),	  which	  showed	  a	  μmax	  of	  
0.49	  ±	  0.02	  h-­‐1	  and	  0.45	  ±	  0.01	  h-­‐1,	  respectively	  (Table	  4).	  However,	  a	  significant	  increase	  can	  be	  
observed	   both	   for	   the	   FucA	   specific	   mass	   and	   FucA	   specific	   activity.	   The	   point	   of	   maximum	  
activity	  corresponds	  to	  1309	  ±	  24	  AU·g-­‐1DCW	  and	  254	  ±	  5	  mgFucA·g-­‐1DCW	  after	  2	  h	  of	  induction.	  
Comparing	  with	   all	   the	   previous	   constructs,	   FucA	   over-­‐production	   in	   the	   final	   antibiotic	   free-­‐
plasmid	  selection	  system	  is	  the	  highest.	  As	  it	  can	  be	  seen	  in	  table	  4,	  M15ΔglyA	  pQE-­‐FucA_puzzle	  
(J23110)_AmpR-­‐	   FucA	   yield	   is:	   i)	  more	   than	   1.4	   fold	   higher	   comparing	  with	   the	  M15pQE-­‐FucA	  
strain;	  ii)	  two-­‐fold	  higher	  comparing	  with	  M15ΔglyA	  pQE-­‐FucA	  +	  pSB1C3	  (J23110)	  and	  M15ΔglyA	  
pQE-­‐FucA_puzzle	   (J23110)	   and	   iii)	   three-­‐	   fold	   higher	   referred	   to	   the	   M15ΔglyA	   strain.	  
Coherently,	   the	   FucA	   activity,	   in	   terms	   of	   AU·∙g-­‐1DCW,	   increased	   through	   the	   different	   strain	  
improvements	   performed	   along	   this	  work,	   reaching	   4.5-­‐fold	   higher	   values	  when	   compared	   to	  
the	   first	  ΔglyA	   strain	  generation.	   In	  parallel,	   the	  acetate	  production,	  expressed	  as	  gAc·∙gDCW-­‐1,	  




	   27	  
	  Tabla	   4	  Maximum	  FucA	  activity	   (AU·∙g-­‐1DCW),	   maximum	   FucA	  mass	   (mg·∙g-­‐1DCW),	  μmax	  and	  maximum	  acetate	  
yield	  (g·∙g-­‐1DCW)	  along	  the	  induction	  phase	  for	  the	  principal	  strains	  presented	  along	  this	  study.	  
E.	  coli	  strains	   FucA	  activity	  (AU·∙g-­‐1DCW)	  
FucA	  mass	  	  	  
(mg·∙g-­‐1DCW)	  
μmax	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(h-­‐1)	  
Acetate	  yield	  	  	  	  	  	  	  	  
(g·∙g-­‐1DCW)	  
M15[pREP4]	  pQE-­‐FucA	   721	  ±	  82	   181	  ±	  5	   0.49	  ±	  0.02	   0.73	  ±	  0.04	  
M15ΔglyA[pREP4]	  	  
pQE-­‐FucA	   291	  ±	  24	   67	  ±	  37	   0.44	  ±	  0.01	   0.90	  ±	  0.04	  
M15ΔglyA	  pQE-­‐FucA	  +	  
pSB1C3	  J23110	   574	  ±	  49	   83	  ±	  7	   0.48	  ±	  0.02	   0.70	  ±	  0.12	  
M15ΔglyA	  pQE-­‐
FucA_puzzle	  (J23110)	   984	  ±	  32	   97	  ±	  14	   0.45	  ±	  0.01	   0.57	  ±	  0.03	  
M15ΔglyA	  pQE-­‐FucA_	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4 Conclusions	  
	  
This	   work	   has	   developed	   a	   novel	   expression	   system	   based	   on	   an	   antibiotic-­‐free	   plasmid	  
maintenance	  mechanism.	  We	  demonstrated	   that	  a	   tuning	  of	   the	  glyA	  and	   lacI	  expression	  was	  
required	   to	   reduce	   metabolic	   burden.	   Although	   the	   overexpression	   of	   the	   plasmid-­‐encoded	  
protein	   of	   interest	   (FucA)	   is	   a	   major	   factor	   in	   the	   metabolic	   burden,	   the	   non-­‐optimized	  
expression	   levels	   of	   lacI	   and	   glyA	   genes,	   coding	   for	   the	   lac	   repressor	   and	   the	   auxotrophic	  
selection	  marker	  protein	  respectively,	  also	  contributed.	  The	  selected	  expression	  cassette	  for	  the	  
lacI	  and	  glyA,	  where	  these	  genes	  have	  been	  placed	  under	  the	  control	  of	  a	  constitutive	  promoter	  
J23110,	   seems	   to	   down	   regulate	   their	   transcriptional	   levels.	   This	   tuning,	   together	   with	   the	  
complete	  deletion	  of	   the	  antibiotic	   resistance	  gene,	   results	   in	   to	  a	   reduction	  of	   the	  metabolic	  
burden	   leading	   to	   a	   better	   stability	   of	   expression	   system	   that,	   ultimately,	   allows	   an	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